BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 35202488)

  • 1. Transmissible cancer influences immune gene expression in an endangered marsupial, the Tasmanian devil (Sarcophilus harrisii).
    Raven N; Klaassen M; Madsen T; Thomas F; Hamede RK; Ujvari B
    Mol Ecol; 2022 Apr; 31(8):2293-2311. PubMed ID: 35202488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmissible cancer and longitudinal telomere dynamics in Tasmanian devils (Sarcophilus harrisii).
    Madsen T; Klaassen M; Raven N; Dujon AM; Jennings G; Thomas F; Hamede R; Ujvari B
    Mol Ecol; 2022 Dec; 31(24):6531-6540. PubMed ID: 36205590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglubolin dynamics and cancer prevalence in Tasmanian devils (Sarcophilus harrisii).
    Ujvari B; Hamede R; Peck S; Pemberton D; Jones M; Belov K; Madsen T
    Sci Rep; 2016 Apr; 6():25093. PubMed ID: 27126067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex associations between cancer progression and immune gene expression reveals early influence of transmissible cancer on Tasmanian devils.
    Raven N; Klaassen M; Madsen T; Jones M; Hamilton DG; Ruiz-Aravena M; Thomas F; Hamede RK; Ujvari B
    Front Immunol; 2024; 15():1286352. PubMed ID: 38515744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Devil Facial Tumor Disease.
    Pye RJ; Woods GM; Kreiss A
    Vet Pathol; 2016 Jul; 53(4):726-36. PubMed ID: 26657222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Season, weight, and age, but not transmissible cancer, affect tick loads in the endangered Tasmanian devil.
    Belkhir S; Hamede R; Thomas F; Ujvari B; Dujon AM
    Infect Genet Evol; 2022 Mar; 98():105221. PubMed ID: 35065301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curse of the devil: molecular insights into the emergence of transmissible cancers in the Tasmanian devil (Sarcophilus harrisii).
    Patchett AL; Flies AS; Lyons AB; Woods GM
    Cell Mol Life Sci; 2020 Jul; 77(13):2507-2525. PubMed ID: 31900624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative landscape genetics reveals differential effects of environment on host and pathogen genetic structure in Tasmanian devils (Sarcophilus harrisii) and their transmissible tumour.
    Kozakiewicz CP; Ricci L; Patton AH; Stahlke AR; Hendricks SA; Margres MJ; Ruiz-Aravena M; Hamilton DG; Hamede R; McCallum H; Jones ME; Hohenlohe PA; Storfer A
    Mol Ecol; 2020 Sep; 29(17):3217-3233. PubMed ID: 32682353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils.
    Pye R; Hamede R; Siddle HV; Caldwell A; Knowles GW; Swift K; Kreiss A; Jones ME; Lyons AB; Woods GM
    Biol Lett; 2016 Oct; 12(10):. PubMed ID: 28120799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmissible cancer in Tasmanian devils: localized lineage replacement and host population response.
    Hamede RK; Pearse AM; Swift K; Barmuta LA; Murchison EP; Jones ME
    Proc Biol Sci; 2015 Sep; 282(1814):. PubMed ID: 26336167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations.
    Kreiss A; Brown GK; Tovar C; Lyons AB; Woods GM
    Vaccine; 2015 Jun; 33(26):3016-25. PubMed ID: 25708088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution in a transmissible cancer: a study of the chromosomal changes in devil facial tumor (DFT) as it spreads through the wild Tasmanian devil population.
    Pearse AM; Swift K; Hodson P; Hua B; McCallum H; Pyecroft S; Taylor R; Eldridge MD; Belov K
    Cancer Genet; 2012 Mar; 205(3):101-12. PubMed ID: 22469509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious disease and sickness behaviour: tumour progression affects interaction patterns and social network structure in wild Tasmanian devils.
    Hamilton DG; Jones ME; Cameron EZ; Kerlin DH; McCallum H; Storfer A; Hohenlohe PA; Hamede RK
    Proc Biol Sci; 2020 Dec; 287(1940):20202454. PubMed ID: 33290679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two of a kind: transmissible Schwann cell cancers in the endangered Tasmanian devil (Sarcophilus harrisii).
    Patchett AL; Coorens THH; Darby J; Wilson R; McKay MJ; Kamath KS; Rubin A; Wakefield M; Mcintosh L; Mangiola S; Pye RJ; Flies AS; Corcoran LM; Lyons AB; Woods GM; Murchison EP; Papenfuss AT; Tovar C
    Cell Mol Life Sci; 2020 May; 77(9):1847-1858. PubMed ID: 31375869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intergenomic signatures of coevolution between Tasmanian devils and an infectious cancer.
    Gallinson DG; Kozakiewicz CP; Rautsaw RM; Beer MA; Ruiz-Aravena M; Comte S; Hamilton DG; Kerlin DH; McCallum HI; Hamede R; Jones ME; Storfer A; McMinds R; Margres MJ
    Proc Natl Acad Sci U S A; 2024 Mar; 121(12):e2307780121. PubMed ID: 38466855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary and historical selection in Tasmanian devils (
    Stahlke AR; Epstein B; Barbosa S; Margres MJ; Patton AH; Hendricks SA; Veillet A; Fraik AK; Schönfeld B; McCallum HI; Hamede R; Jones ME; Storfer A; Hohenlohe PA
    Proc Biol Sci; 2021 May; 288(1951):20210577. PubMed ID: 34034517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin and carboplatin trials in Tasmanian devils (Sarcophilus harrisii) with Tasmanian devil facial tumor disease.
    Phalen DN; Frimberger AE; Peck S; Pyecroft S; Harmsen C; Lola S; Moore AS
    Vet J; 2015 Dec; 206(3):312-6. PubMed ID: 26538144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial variation in gene expression of Tasmanian devil facial tumors despite minimal host transcriptomic response to infection.
    Kozakiewicz CP; Fraik AK; Patton AH; Ruiz-Aravena M; Hamilton DG; Hamede R; McCallum H; Hohenlohe PA; Margres MJ; Jones ME; Storfer A
    BMC Genomics; 2021 Sep; 22(1):698. PubMed ID: 34579650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils.
    Tovar C; Pye RJ; Kreiss A; Cheng Y; Brown GK; Darby J; Malley RC; Siddle HV; Skjødt K; Kaufman J; Silva A; Baz Morelli A; Papenfuss AT; Corcoran LM; Murphy JM; Pearse MJ; Belov K; Lyons AB; Woods GM
    Sci Rep; 2017 Mar; 7():43827. PubMed ID: 28276463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of Cryptosporidium and Giardia from the Tasmanian devil (Sarcophilus harrisii).
    Wait LF; Fox S; Peck S; Power ML
    PLoS One; 2017; 12(4):e0174994. PubMed ID: 28423030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.